| Filed On | Filing |
|---|---|
| 29 Apr 2025 |
Form 3: Sinha Vikas, Chief Financial Officer
No securities owned |
| 29 Apr 2025 |
Form 3: Woods Keith, Chief Operating Officer
No securities owned |
| 21 Mar 2025 |
Form 3: Moore Erin, Interim PFO and PAO
Holds 82,609 shares of Common Stock |
| 29 Jul 2024 |
Form 3: Siren, L.l.c., 10% owner and 2 others
Holds 11,259,438 shares of Common Stock |
| 15 Feb 2024 |
Form 3: Peng Katie, Director
No securities owned |
| 22 Jun 2023 | Form 3: Sacco Tracey, Chief Commercial Officer |
| 22 Jun 2023 |
Form 3: Qatanani Mo, SVP and Head of Research
Holds 21,000 shares of Common Stock |
| 21 Jun 2023 |
Form 3: Samsara BioCapital GP, Llc, 10% owner and 1 other
Holds 4,598,828 shares of Common Stock |
| 10 Apr 2023 |
Form 3: Brudnick Richard, Director
No securities owned |
| 15 Nov 2022 |
Form 3: Marantz Jing L., Chief Medical Officer
No securities owned |
| 22 Sep 2022 |
Form 3: Backstrom Jay T., CEO-Elect
No securities owned |
| 28 Jul 2022 |
Form 3: Akkaraju Srinivas, Director
Holds 4,598,828 shares of Common Stock |
| 24 Jun 2022 |
Form 3: Invus Public Equities, L.p., 10% owner and 7 others
Holds 8,750,034 shares of Common Stock |
| 26 May 2022 |
Form 3: Parlavecchio Caryn, CHRO
Holds 16,800 shares of Common Stock |
| 10 Aug 2021 |
Form 3: Mahanthappa Nagesh K., Director
Holds 380,491 shares of Common Stock |
| 25 Jun 2021 |
Form 3: Ho Junlin, General Counsel
Holds 11,550 shares of Common Stock |
| 18 Mar 2021 |
Form 3: Reed Joshua, Director
No securities owned |
| 18 Jun 2020 |
Form 3: Carven Gregory John, Head of Research
Holds 45,215 shares of Common Stock |
| 21 May 2020 |
Form 3: Kingsley Stuart A, Director
No securities owned |
| 10 Oct 2019 | Form 3: Moore Erin, SVP, Finance |
Loading...
